Extensive experience in structuring and managing risk sharing deals in various roles worth over $1 billion USD. Extensive experience in clinical research across the pharmaceutical and CRO industry, spanning US, Europe and Asia. Key Opinion Leader to Korean Health Industry Development Institute. Previously held senior business development and management roles at IQVIA, EPS International and ICON. Master’s Degree in Pharmaceutical Sciences from Kingston University with research focus in Aromatase inhibitors in Breast cancer. Bachelor of Pharmacy from University of Mumbai.